Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance

por Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner
Publicado 2018

MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.

por Barbara M Grüner, Hannes Hahne, Pawel K Mazur, Marija Trajkovic-Arsic, Stefan Maier, Irene Esposito, Evdokia Kalideris, Christoph W Michalski, Jörg Kleeff, Sandra Rauser, Roland M Schmid, Bernhard Küster, Axel Walch, Jens T Siveke
Publicado 2012